No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy

No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2017-05, Vol.31 (8), p.1137-1141
Hauptverfasser: MOTA, Talia M, RASMUSSEN, Thomas A, RHODES, Ajantha, TENNAKOON, Surekha, DANTANARAYANA, Ashanti, WIGHTMAN, Fiona, HAGENAUER, Michelle, RONEY, Janine, SPELMAN, Tim, PURCELL, Damian FJ, McMAHON, James, HOY, Jennifer F, PRINCE, H. Miles, ELLIOTT, Julian H, LEWIN, Sharon R
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1141
container_issue 8
container_start_page 1137
container_title AIDS (London)
container_volume 31
creator MOTA, Talia M
RASMUSSEN, Thomas A
RHODES, Ajantha
TENNAKOON, Surekha
DANTANARAYANA, Ashanti
WIGHTMAN, Fiona
HAGENAUER, Michelle
RONEY, Janine
SPELMAN, Tim
PURCELL, Damian FJ
McMAHON, James
HOY, Jennifer F
PRINCE, H. Miles
ELLIOTT, Julian H
LEWIN, Sharon R
description
doi_str_mv 10.1097/QAD.0000000000001442
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5496768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5496768</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_54967683</originalsourceid><addsrcrecordid>eNqljL1KxEAUhQdR3Kz6Bhb3BbJO_pNGEHVZG2FBbMOY3CRXsnPDzGyWFL67U1ho7WkOh_PxCXEbyU0kq-Ju__C0kb8SpWl8JoIoLZIwy4roXAQyzquwSgq5EmtrPz2UybK8FKu4TDwfJ4H4emVQ7YzGIljVoVuADcxkeOSeGjVCMyjdowV3YlhQGQsdjyOfSPcwsyHN1ikHpGH38h6S7rBx2Prd0kztUY0WWIPSjgw6w17tpW5Ao6blWlx0HsCbn74S99vnt8ddOB0_Dtg2qJ2n68nQQZmlZkX130fTUPc811la5UVeJv8WfAOEyHED</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>MOTA, Talia M ; RASMUSSEN, Thomas A ; RHODES, Ajantha ; TENNAKOON, Surekha ; DANTANARAYANA, Ashanti ; WIGHTMAN, Fiona ; HAGENAUER, Michelle ; RONEY, Janine ; SPELMAN, Tim ; PURCELL, Damian FJ ; McMAHON, James ; HOY, Jennifer F ; PRINCE, H. Miles ; ELLIOTT, Julian H ; LEWIN, Sharon R</creator><creatorcontrib>MOTA, Talia M ; RASMUSSEN, Thomas A ; RHODES, Ajantha ; TENNAKOON, Surekha ; DANTANARAYANA, Ashanti ; WIGHTMAN, Fiona ; HAGENAUER, Michelle ; RONEY, Janine ; SPELMAN, Tim ; PURCELL, Damian FJ ; McMAHON, James ; HOY, Jennifer F ; PRINCE, H. Miles ; ELLIOTT, Julian H ; LEWIN, Sharon R</creatorcontrib><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0000000000001442</identifier><identifier>PMID: 28301423</identifier><language>eng</language><ispartof>AIDS (London), 2017-05, Vol.31 (8), p.1137-1141</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids></links><search><creatorcontrib>MOTA, Talia M</creatorcontrib><creatorcontrib>RASMUSSEN, Thomas A</creatorcontrib><creatorcontrib>RHODES, Ajantha</creatorcontrib><creatorcontrib>TENNAKOON, Surekha</creatorcontrib><creatorcontrib>DANTANARAYANA, Ashanti</creatorcontrib><creatorcontrib>WIGHTMAN, Fiona</creatorcontrib><creatorcontrib>HAGENAUER, Michelle</creatorcontrib><creatorcontrib>RONEY, Janine</creatorcontrib><creatorcontrib>SPELMAN, Tim</creatorcontrib><creatorcontrib>PURCELL, Damian FJ</creatorcontrib><creatorcontrib>McMAHON, James</creatorcontrib><creatorcontrib>HOY, Jennifer F</creatorcontrib><creatorcontrib>PRINCE, H. Miles</creatorcontrib><creatorcontrib>ELLIOTT, Julian H</creatorcontrib><creatorcontrib>LEWIN, Sharon R</creatorcontrib><title>No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy</title><title>AIDS (London)</title><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqljL1KxEAUhQdR3Kz6Bhb3BbJO_pNGEHVZG2FBbMOY3CRXsnPDzGyWFL67U1ho7WkOh_PxCXEbyU0kq-Ju__C0kb8SpWl8JoIoLZIwy4roXAQyzquwSgq5EmtrPz2UybK8FKu4TDwfJ4H4emVQ7YzGIljVoVuADcxkeOSeGjVCMyjdowV3YlhQGQsdjyOfSPcwsyHN1ikHpGH38h6S7rBx2Prd0kztUY0WWIPSjgw6w17tpW5Ao6blWlx0HsCbn74S99vnt8ddOB0_Dtg2qJ2n68nQQZmlZkX130fTUPc811la5UVeJv8WfAOEyHED</recordid><startdate>20170515</startdate><enddate>20170515</enddate><creator>MOTA, Talia M</creator><creator>RASMUSSEN, Thomas A</creator><creator>RHODES, Ajantha</creator><creator>TENNAKOON, Surekha</creator><creator>DANTANARAYANA, Ashanti</creator><creator>WIGHTMAN, Fiona</creator><creator>HAGENAUER, Michelle</creator><creator>RONEY, Janine</creator><creator>SPELMAN, Tim</creator><creator>PURCELL, Damian FJ</creator><creator>McMAHON, James</creator><creator>HOY, Jennifer F</creator><creator>PRINCE, H. Miles</creator><creator>ELLIOTT, Julian H</creator><creator>LEWIN, Sharon R</creator><scope>5PM</scope></search><sort><creationdate>20170515</creationdate><title>No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy</title><author>MOTA, Talia M ; RASMUSSEN, Thomas A ; RHODES, Ajantha ; TENNAKOON, Surekha ; DANTANARAYANA, Ashanti ; WIGHTMAN, Fiona ; HAGENAUER, Michelle ; RONEY, Janine ; SPELMAN, Tim ; PURCELL, Damian FJ ; McMAHON, James ; HOY, Jennifer F ; PRINCE, H. Miles ; ELLIOTT, Julian H ; LEWIN, Sharon R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_54967683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MOTA, Talia M</creatorcontrib><creatorcontrib>RASMUSSEN, Thomas A</creatorcontrib><creatorcontrib>RHODES, Ajantha</creatorcontrib><creatorcontrib>TENNAKOON, Surekha</creatorcontrib><creatorcontrib>DANTANARAYANA, Ashanti</creatorcontrib><creatorcontrib>WIGHTMAN, Fiona</creatorcontrib><creatorcontrib>HAGENAUER, Michelle</creatorcontrib><creatorcontrib>RONEY, Janine</creatorcontrib><creatorcontrib>SPELMAN, Tim</creatorcontrib><creatorcontrib>PURCELL, Damian FJ</creatorcontrib><creatorcontrib>McMAHON, James</creatorcontrib><creatorcontrib>HOY, Jennifer F</creatorcontrib><creatorcontrib>PRINCE, H. Miles</creatorcontrib><creatorcontrib>ELLIOTT, Julian H</creatorcontrib><creatorcontrib>LEWIN, Sharon R</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MOTA, Talia M</au><au>RASMUSSEN, Thomas A</au><au>RHODES, Ajantha</au><au>TENNAKOON, Surekha</au><au>DANTANARAYANA, Ashanti</au><au>WIGHTMAN, Fiona</au><au>HAGENAUER, Michelle</au><au>RONEY, Janine</au><au>SPELMAN, Tim</au><au>PURCELL, Damian FJ</au><au>McMAHON, James</au><au>HOY, Jennifer F</au><au>PRINCE, H. Miles</au><au>ELLIOTT, Julian H</au><au>LEWIN, Sharon R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy</atitle><jtitle>AIDS (London)</jtitle><date>2017-05-15</date><risdate>2017</risdate><volume>31</volume><issue>8</issue><spage>1137</spage><epage>1141</epage><pages>1137-1141</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><pmid>28301423</pmid><doi>10.1097/QAD.0000000000001442</doi></addata></record>
fulltext fulltext
identifier ISSN: 0269-9370
ispartof AIDS (London), 2017-05, Vol.31 (8), p.1137-1141
issn 0269-9370
1473-5571
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5496768
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
title No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A07%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20adverse%20safety%20or%20virological%20changes%20two%20years%20following%20vorinostat%20in%20HIV-infected%20individuals%20on%20antiretroviral%20therapy&rft.jtitle=AIDS%20(London)&rft.au=MOTA,%20Talia%20M&rft.date=2017-05-15&rft.volume=31&rft.issue=8&rft.spage=1137&rft.epage=1141&rft.pages=1137-1141&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0000000000001442&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5496768%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28301423&rfr_iscdi=true